248 related articles for article (PubMed ID: 8878051)
1. Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.
Zgombick JM; Schechter LE; Adham N; Kucharewicz SA; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):226-36. PubMed ID: 8878051
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
Pauwels PJ; Palmier C; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
[TBL] [Abstract][Full Text] [Related]
3. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
4. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):136-44. PubMed ID: 8857590
[TBL] [Abstract][Full Text] [Related]
5. Native 5-HT1B receptors expressed in OK cells display dual coupling to elevation of intracellular calcium concentrations and inhibition of adenylate cyclase.
Zgombick JM; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):503-8. PubMed ID: 9840417
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways.
Adham N; Borden LA; Schechter LE; Gustafson EL; Cochran TL; Vaysse PJ; Weinshank RL; Branchek TA
Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):566-75. PubMed ID: 8133900
[TBL] [Abstract][Full Text] [Related]
7. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
8. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
9. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
10. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
11. Differentiation between partial and silent 5-HT1D beta receptor antagonists using rat C6-glial and Chinese hamster ovary cell lines permanently transfected with a cloned human 5-HT1D beta receptor gene.
Pauwels PJ; Colpaert FC
Biochem Pharmacol; 1995 Nov; 50(10):1651-8. PubMed ID: 7503768
[TBL] [Abstract][Full Text] [Related]
12. Functional serotonin 5-HT1D receptors and 5-HT1D beta receptor mRNA expression in human umbilical vein endothelial cells.
Schoeffter P; Ullmer C; Gutierrez M; Weitz-Schmidt G; Lübbert H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):580-2. PubMed ID: 8751089
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by 5-HT of forskolin-induced cAMP formation in the renal opossum epithelial cell line OK: mediation by a 5-HT1B like receptor and antagonism by methiothepin.
Pauwels PJ; Palmier C
Neuropharmacology; 1994 Jan; 33(1):67-75. PubMed ID: 7910388
[TBL] [Abstract][Full Text] [Related]
14. GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors.
Watson JM; Burton MJ; Price GW; Jones BJ; Middlemiss DN
Eur J Pharmacol; 1996 Oct; 314(3):365-72. PubMed ID: 8957260
[TBL] [Abstract][Full Text] [Related]
15. Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan.
Miller KJ; King A; Demchyshyn L; Niznik H; Teitler M
Eur J Pharmacol; 1992 Sep; 227(1):99-102. PubMed ID: 1330643
[TBL] [Abstract][Full Text] [Related]
16. Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase.
Adham N; Kao HT; Schecter LE; Bard J; Olsen M; Urquhart D; Durkin M; Hartig PR; Weinshank RL; Branchek TA
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):408-12. PubMed ID: 8380639
[TBL] [Abstract][Full Text] [Related]
17. The activity of 5-HT1D receptor ligands at cloned human 5-HT1D alpha and 5-HT1D beta receptors.
Walsh DM; Beattie DT; Connor HE
Eur J Pharmacol; 1995 Dec; 287(1):79-84. PubMed ID: 8666030
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
Adham N; Zgombick JM; Bard J; Branchek TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
[TBL] [Abstract][Full Text] [Related]
19. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
[TBL] [Abstract][Full Text] [Related]
20. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
